These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12698500)

  • 1. Pharmacokinetics of an ultralong sustained-release theophylline formulation when given twice daily in elderly patients with chronic obstructive pulmonary disease: monitoring implications.
    Armijo JA; Sánchez BM; Peralta FG; González-Ruiz M; Cuadrado A; Verdejo A; Cos MA; Arjona R
    Biopharm Drug Dispos; 2003 May; 24(4):165-71. PubMed ID: 12698500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
    Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative dose study of a theophylline sustained-release tablet formulation after repeated administrations.
    Cova D; Cuglituri G; Rossini L; Bonfardeci G
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):273-5. PubMed ID: 2737795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
    Wang P; Qi M; Zhong D; Fang L
    Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
    Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
    Iwasaki E; Baba M
    Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
    Götz J; Sauter R; Steinijans VW; Jonkman JH
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline therapeutic drug monitoring in the case of a new sustained-release pellet formulation for once-daily evening administration.
    Steinijans VW; Trautmann H; Sauter R; Staudinger H
    Arzneimittelforschung; 1988 Aug; 38(8A):1251-3. PubMed ID: 3190814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
    Okuma M; Iikura Y
    Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of cefonicid on the pharmacokinetics of a once-a-day theophylline formulation.
    Cazzola M; Lobefalo G; Lupis F; Vanacore L; Martucci P; D'Amato G
    Int J Clin Pharmacol Res; 1989; 9(3):169-73. PubMed ID: 2663736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
    Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
    Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
    Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of the single point method for theophylline maintenance dose prediction.
    Abad J; Pastor A; Prieto L; Palop J; Jiménez Torres V; Castro J
    Allergol Immunopathol (Madr); 1987; 15(6):355-9. PubMed ID: 3445876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease.
    Tompson DJ; Vearer D
    Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
    Bachmann K; Jauregui L; Sides G; Sullivan TJ
    J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
    Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
    Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-interference of xibornol on the theophylline blood levels.
    Fraschini F; Scaglione F; Maierna G; Savio G; Gattei G; Falchi M
    Int J Clin Pharmacol Res; 1988; 8(1):43-6. PubMed ID: 3366502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of plasma levels of 2 delayed-action theophyllines: Theostat 200 and Theodur 200, after a single evening dose].
    Philip-Joet F; Bruguerolle B; Lagier F; Arnaud A
    Rev Pneumol Clin; 1986; 42(6):279-83. PubMed ID: 3563255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.